C3 activation is inhibited by analogs of compstatin but not by serine protease inhibitors or peptidyl -ketoheterocycles

Author： Furlong S.T.   Dutta A.S.   Coath M.M.   Gormley J.J.   Hubbs S.J.   Lloyd D.   Mauger R.C.   Strimpler A.M.   Sylvester M.A.   Scott C.W.   Edwards P.D.  

Publisher： Elsevier

ISSN： 0162-3109

Source： Immunopharmacology, Vol.48, Iss.2, 2000-07, pp. : 199-212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel tripeptide inhibitors of hepatitis C virus NS3 serine protease

By  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 267-272

Informa Healthcare

Access to resources Recommend Favorite

Peptidic Inhibitors of the Hepatitis C Virus Serine Protease within Non- Structural Protein 3

By  

Current Pharmaceutical Design, Vol. 8, Iss. 28, 2002-12 ,pp. : 2533-2540

Bentham Science Publishers

Access to resources Recommend Favorite

Hepatitis C Virus Serine Protease Inhibitors: Current Progress and Future Challenges

By  

Current Medicinal Chemistry, Vol. 8, Iss. 8, 2001-07 ,pp. : 919-932

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR and Docking Studies of HCV NS3 Serine Protease Inhibitors

By  

Medicinal Chemistry, Vol. 9, Iss. 6, 2013-09 ,pp. : 774-805

Bentham Science Publishers

Access to resources Recommend Favorite

Computer-Assisted Analysis of the Interactions of Macrocyclic Inhibitors with wild Type and Mutant D168A Hepatitis C Virus NS3 Serine Protease

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 1, 2006-02 ,pp. : 17-28

Bentham Science Publishers

Access to resources Recommend Favorite